Predictive value of NGAL for use of renal replacement therapy in patients with severe sepsis

Acta Anaesthesiologica Scandinavica

Volumn 59, Issue 1, 2015, Pages 25-34

  Hjortrup, P B ^a   Haase, N ^a   Treschow, F ^b   MOller M H ^c   Perner, A ^a  

^a Rigshospitalet   (Denmark)

^b HOLBÆK HOSPITAL   (Denmark)

^c Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; POTASSIUM; SODIUM; UREA; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ABDOMINAL INFECTION; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD ANALYSIS; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DIABETES MELLITUS; FEMALE; FLUID RESUSCITATION; HUMAN; IMMUNOASSAY; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SODIUM BLOOD LEVEL; SOFT TISSUE INFECTION; TURBIDIMETRY; UREA BLOOD LEVEL; URINALYSIS; URINARY TRACT INFECTION; URINE LEVEL; ACUTE KIDNEY INJURY; BLOOD; CLINICAL TRIAL; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ADULT; AGED; CREATININE; FEMALE; HUMANS; LIPOCALINS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RENAL REPLACEMENT THERAPY; ROC CURVE; SEPSIS;

EID: 84916241060     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12427     Document Type: Article

References (36)

1. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, Macleod A,. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007; 18: 1292-1298.
2. Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C,. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34: 1913-1917.
3. Kjeldsen L, Cowland JB, Borregaard N,. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 2000; 1482: 272-283.
4. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK,. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002; 10: 1033-1043.
5. Roudkenar MH, Halabian R, Roushandeh AM, Nourani MR, Masroori N, Ebrahimi M, Nikogoftar M, Rouhbakhsh M, Bahmani P, Najafabadi AJ, Shokrgozar MA,. Lipocalin 2 regulation by thermal stresses: protective role of Lcn2/NGAL against cold and heat stresses. Exp Cell Res 2009; 315: 3140-3151.
6. Fjaertoft G, Foucard T, Xu S, Venge P,. Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: a study of the kinetics. Acta Paediatr 2005; 94: 661-666.
7. Xu SY, Pauksen K, Venge P,. Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest 1995; 55: 125-131.
8. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P,. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-1238.
9. Siew ED, Ware LB, Gebretsadik T, Shintani A, Moons KGM, Wickersham N, Bossert F, Ikizler TA,. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol 2009; 20: 1823-1832.
10. Cruz DN, de Cal M, Garzotto F, Perazella MA, Lentini P, Corradi V, Piccinni P, Ronco C,. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2010; 36: 444-451.
11. Constantin J-M, Futier E, Perbet S, Roszyk L, Lautrette A, Gillart T, Guerin R, Jabaudon M, Souweine B, Bazin J-E, Sapin V,. Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study. J Crit Care 2010; 25: 176, e1-6.
12. Endre ZH, Pickering JW, Walker RJ, Devarajan P, Edelstein CL, Bonventre JV, Frampton CM, Bennett MR, Ma Q, Sabbisetti VS, Vaidya VS, Walcher AM, Shaw GM, Henderson SJ, Nejat M, Schollum JBW, George PM,. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011; 79: 1119-1130.
13. De Geus HRH, Bakker J, Lesaffre EMEH, le Noble JLML,. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 2011; 183: 907-914.
14. Doi K, Negishi K, Ishizu T, Katagiri D, Fujita T, Matsubara T, Yahagi N, Sugaya T, Noiri E,. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med 2011; 39: 2464-2469.
15. Metzger J, Kirsch T, Schiffer E, Ulger P, Mentes E, Brand K, Weissinger EM, Haubitz M, Mischak H, Herget-Rosenthal S,. Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury. Kidney Int 2010; 78: 1252-1262.
16. Nisula S, Yang R, Kaukonen K-M, Vaara ST, Kuitunen A, Tenhunen J, Pettilä V, Korhonen AM,. The urine protein NGAL predicts renal replacement therapy, but not acute kidney injury or 90-day mortality in critically ill adult patients. Anesth Analg 2014; 119: 95-102.
17. Hjortrup PB, Haase N, Wetterslev M, Perner A,. Clinical review: predictive value of neutrophil gelatinase-associated lipocalin (NGAL) for acute kidney injury in intensive care patients. Crit Care 2013; 17: 211.
18. Linko R, Pettilä V, Kuitunen A, Korhonen A-M, Nisula S, Alila S, Kiviniemi O, Laru-Sompa R, Varpula T, Karlsson S,. Plasma neutrophil gelatinase-associated lipocalin and adverse outcome in critically ill patients with ventilatory support. Acta Anaesthesiol Scand 2013; 57: 855-862.
19. Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R,. Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med 2008; 36: S198-203.
20. Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W,. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 2013; 28: 254-273.
21. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard A-L, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J,. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124-134.
22. Perner A, Haase N, Wetterslev J, Aneman A, Tenhunen J, Guttormsen AB, Klemenzson G, Pott F, Bødker KD, Bådstøløkken PM, Bendtsen A, Søe-Jensen P, Tousi H, Bestle M, Pawlowicz M, Winding R, Bülow H-H, Kancir C, Steensen M, Nielsen J, Fogh B, Madsen KR, Larsen NH, Carlsson M, Wiis J, Petersen JA, Iversen S, Schøidt O, Leivdal S, Berezowicz P, Pettilä V, Ruokonen E, Klepstad P, Karlsson S, Kaukonen M, Rutanen J, Karason S, Kjældgaard AL, Holst LB, Wernerman J,. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S -Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded randomised clinical trial. Trials 2011; 12: 24.
23. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibblad WJ,. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
24. Pedersen KB., The NGAL test application note. Available at: http://www.ngal.com/media/53415/the-ngal-test-roche-cobas-c501-ivd.pdf (accessed 14 October 2014).
25. Kellum JA, Lameire N,. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care 2013; 17: 204.
26. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P,. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-212.
27. Waikar SS, Sabbisetti VS, Bonventre JV,. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 2010; 78: 486-494.
28. Ralib AM, Pickering JW, Shaw GM, Devarajan P, Edelstein CL, Bonventre JV, Endre ZH,. Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol 2012; 23: 322-333.
29. Delanaye P, Rozet E, Krzesinski J-M, Cavalier E,. Urinary NGAL measurement: biological variation and ratio to creatinine. Clin Chim Acta 2011; 412: 390.
30. DeLong ER, DeLong DM, Clarke-Pearson DL,. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
31. Mårtensson J, Bell M, Xu S, Bottai M, Ravn B, Venge P, Martling C-R,. Association of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney dysfunction. Biomarkers 2013; 18: 349-356.
32. Lerolle N, Nochy D, Guérot E, Bruneval P, Fagon J-Y, Diehl J-L, Hill G,. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med 2010; 36: 471-478.
33. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Martensson J, Martling C-R, Venge P, Siew E, Ware LB, Ikizler TA, Mertens PR,. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011; 57: 1752-1761.
34. Mårtensson J, Xu S, Bell M, Martling C-R, Venge P,. Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils. Clin Chim Acta 2012; 413: 1661-1667.
35. Glassford NJ, Schneider AG, Xu S, Eastwood GM, Young H, Peck L, Venge P, Bellomo R,. The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injury. Intensive Care Med 2013; 39: 1714-1724.
36. Grenier FC, Ali S, Syed H, Workman R, Martens F, Liao M, Wang Y, Wong P-Y,. Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem 2010; 43: 615-620.